Ginkgo Bioworks Holdings Total Liabilities 2020-2023 | DNA
Ginkgo Bioworks Holdings total liabilities from 2020 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
Ginkgo Bioworks Holdings Annual Total Liabilities
(Millions of US $) |
| 2022 |
$803 |
| 2021 |
$504 |
| 2020 |
$205 |
| 2019 |
$0 |
Ginkgo Bioworks Holdings Quarterly Total Liabilities
(Millions of US $) |
| 2023-03-31 |
$810 |
| 2022-12-31 |
$803 |
| 2022-09-30 |
$431 |
| 2022-06-30 |
$427 |
| 2022-03-31 |
$444 |
| 2021-12-31 |
$504 |
| 2021-09-30 |
$533 |
| 2021-06-30 |
$1,721 |
| 2021-03-31 |
$1,723 |
| 2020-12-31 |
|
| 2020-09-30 |
$0 |
| 2019-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.379B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
